News

Compound from Tropical Plant Targets Key Cancer-Causing Genes

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.

Monday, July 28, 2014
Pictured: Gabriela Chiosis
Hsp90: A Very Promising Target for Cancer Therapy

A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.

Thursday, July 17, 2014
Memorial Sloan Kettering Transforms Cancer Research and Care Delivery

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.

Friday, July 11, 2014
Pictured: Gum ball machines
What Is Tumor Heterogeneity?

Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.

Wednesday, July 2, 2014
Pictured: 2014 Summer Undergraduate Research Program
Our 2014 Summer Undergraduate Research Program Begins

The Gerstner Sloan Kettering Summer Undergraduate Research Program has welcomed 24 students to Sloan Kettering Institute labs for a ten-week course of study mentored by GSK faculty.

Wednesday, June 11, 2014
Pictured: Activated macrophage
Researchers Reveal How Tumors Manipulate Certain Immune Cells to Their Own Advantage

Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.

Thursday, June 5, 2014
Pictured: David Solit
At Work: Physician-Scientist David Solit

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Tuesday, May 27, 2014
Pictured: 2014 Graduates
Memorial Sloan Kettering Celebrates at Convocation and Commencement Ceremony

Degrees were presented and awards were given at the 35th annual ceremony held on May 14.

Friday, May 23, 2014
Pictured: José Baselga, Agnès Viale,  Michael Berger & David Solit
Bold Initiative to Transform Cancer Care Established with a $100 Million Gift

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

Tuesday, May 20, 2014
Pictured: Liver Cells
What Is Apoptosis?

Cell biologist Michael Overholtzer explains apoptosis, a form of programmed cell death that can lead to cancer when it doesn’t function properly.

Friday, May 16, 2014